Arthur G James Cancer Hospital and Research Institute

I am an otolaryngologist whose primary focus is providing the very best care for our head and neck cancer patients. I do this by combining my 20 years of surgical experience with the expertise of colleagues who can provide radiation and medical therapies if needed as well as with those who provide support for patients as they recover from treatment. As a team, we work together with patients to find the treatments that have the best chance of curing their cancer while minimizing side effects. After originally joining the OSUCCC - James in 2015 as director of the Head and Neck Oncologic Surgery Division and the Head and Neck Service Line, I currently serve as Chair of the Department of Otolaryngology-Head and Neck Surgery and director of the Head and Neck Disease Specific Research Group. I was also named to the Castle Connolly list of "Regional Top Doctors" from 2011-2019 and hold the Mary E. and John W. Alford Research Chair in Head and Neck Cance s a member of the Translational Therapeutics Program at the OSUCCC - James, my research focuses on the origins of intra-tumor heterogeneity during tumor development, novel biomarkers for head and neck cancer, molecular mechanisms that these biomarkers represent and how these biomarkers might inform decisions about therapy. I'm also actively involved in clinical trials at The James and help direct nationwide efforts through my service on the NRG Oncology and ECOG-ACRIN head and neck committees, and as co-chair of the NCI Head and Neck Task Force on Metastatic and Recurrent Diseas dditionally, I have co-authored many articles in well-known publications, including Cancer Cell, Cell, PLoS Medicine, Journal of Clinical Oncology, Journal of Clinical Investigation, Cancer Research, Clinical Cancer Research, Genome Research and Cance orking at the OSUCCC - James is very inspiring. Everyone is committed to cutting-edge research methods and developing crucial relationships with our patients so we can provide